Remimazolam offers a favorable balance between efficacy and safety, with advantages in hemodynamic stability, reduced respiratory depression, and rapid recovery. While higher acquisition costs may limit widespread adoption, potential efficiencies in procedural throughput and patient safety support its growing role in modern anesthetic practice. Although higher acquisition cost and limited availability remain barriers, its procedural efficiency and safety profile support its growing role in anesthesia and sedation practice.